BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The offering is subject to market conditions, with proceeds intended for gold bullion purchases and general corporate use.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offering Details
Shares of common stock (or pre-funded warrants) are being offered by the company with the net proceeds designated for specific purposes.
Joint Book-Running Managers
Clear Street and Needham & Company are involved in managing the public offering.
Registration Statement
The offering is made pursuant to a shelf registration statement on Form S-3, declared effective by the SEC in December 2024.
- BioSig's decision to offer shares signals its strategic initiative to raise capital for gold bullion purchases and corporate operations.
- The involvement of reputable book-running managers enhances the credibility and market perception of the offering.
BioSig Technologies Inc.'s public offering announcement reflects its proactive approach to funding strategies, potentially indicating growth opportunities ahead.